CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $14,181,000 | +54.1% | 953,711 | +157.2% | 0.30% | +37.2% |
| Q1 2019 | $9,204,000 | -49.0% | 370,840 | -63.1% | 0.22% | -49.2% |
| Q4 2018 | $18,054,000 | +11.0% | 1,005,237 | +226.2% | 0.43% | +20.2% |
| Q1 2018 | $16,269,000 | -65.0% | 308,119 | -55.0% | 0.36% | -66.5% |
| Q4 2017 | $46,548,000 | +8.1% | 684,536 | +31.1% | 1.07% | -1.9% |
| Q3 2017 | $43,041,000 | -19.0% | 522,345 | -8.0% | 1.09% | -16.2% |
| Q2 2017 | $53,154,000 | +240.9% | 567,700 | +131.8% | 1.30% | +258.6% |
| Q1 2017 | $15,593,000 | -61.2% | 244,900 | -72.9% | 0.36% | -60.2% |
| Q4 2016 | $40,147,000 | +110.1% | 903,800 | +70.6% | 0.91% | +100.0% |
| Q3 2016 | $19,104,000 | +105.2% | 529,911 | -21.9% | 0.46% | +105.0% |
| Q2 2016 | $9,308,000 | – | 678,410 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |